The DAIDS Immunology Quality Assessment Program (IQA) will continue to design and execute proficiency testing programs that periodically assess the ability of laboratories to perform tests correctly, and to provide assistance and training when laboratories have difficulties associated with the HIV/AIDS clinical trial units. Also, the IQA will continue to be a flexible, responsive resource to facilitate the adaptation, standardization and quality assessment of new immunological assay methodologies used in therapeutic, vaccine, prevention, epidemiological and preclinical NIAID investigations. Knowing the broad range of factors affecting assay variability, statisticians are able to determine the appropriate study sample size and design appropriate statistical analysis plans. This, in turn, allows investigators to know if a change in test results is due to an intervention or to inherent assay variability.

Agency
National Institute of Health (NIH)
Type
Research and Development Contracts (N01)
Project #
272200700054C-8-0-1
Application #
8730027
Study Section
Project Start
2013-09-30
Project End
2014-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$1,440,222
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705